Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
freem
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Openai/694257a5-9a50-8004-b15d-8af3ca7857db
Add languages
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Special pages
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{DISPLAYTITLE:JAMA New Issue Summary}} ''This conversation was exported from ChatGPT''<ref>{{cite web|title=JAMA New Issue Summary|url=https://chatgpt.com/share/694257a5-9a50-8004-b15d-8af3ca7857db|publisher=ChatGPT|access-date=2025-12-18}}</ref> == gpt-5-2-pro == === User: 原始郵件 === 原始郵件 郵件 ID <1940166960.6793751.1765927265153@email.jamanetwork.com> 建立時間： 2025年12月17日清晨7:21 (傳輸時間：2 秒) 寄件者： JAMA <updates@email.jamanetwork.com> 收件者： friend <copper.wang@gmail.com> 主旨： New issue: Update to SOFA Score in Critically Ill Patients (SOFA-2), AI vs Human Coaching for Diabetes Prevention, Cutaneous Melanoma Review SPF： PASS，IP 74.214.206.14 瞭解詳情 DKIM： 'PASS'，網域 email.jamanetwork.com。瞭解詳情 DMARC： 'PASS'。瞭解詳情 下載原始郵件 複製到剪貼簿 Delivered-To: copper.wang@gmail.com Received: by 2002:a05:7000:dd4f:b0:7b5:6e26:e0d3 with SMTP id lb15csp862660mab; Tue, 16 Dec 2025 15:21:07 -0800 (PST) X-Google-Smtp-Source: AGHT+IEAI4nmNByPkRRTRz8xNTA4Xt63WP8atGZ3Wa8OL+PXoZ/ly9yWQac/Fe5cF521uqbh2xA+ X-Received: by 2002:a05:620a:1927:b0:8b2:ed01:b65b with SMTP id af79cd13be357-8bb3a383aeemr2018942585a.83.1765927267588; Tue, 16 Dec 2025 15:21:07 -0800 (PST) ARC-Seal: i=1; a=rsa-sha256; t=1765927267; cv=none; d=google.com; s=arc-20240605; b=MLhuGFdtB84c3FJI6nPE30Tc4eL+GRksDbe8a56PvV7bBIZMNz7UnnIEnx5aJSYBLc tARsOVC7smR0f8d2YyYUSZs6OqN6voq3oi8rYhPVFOh+F5+g8lOJrOqSyc5i0DnvaNes 0kLcPVvBiB411PkyMQ1EvUPol2pSwWf34mOyAV/Bq+nM42P4ALouGSsKobrL7G2bTwlo pZWxrK/bZmhFjAxz2w9E6YurNRKoGSLWLLuwxqq9rY1TRv29xYrgzQcthp2UC+igyMnh 4wRAwDcpCWC+z2Gd5iQhojum60regz+/mfYLpQSmCDsMltg+L0caiTeA0yyE0LWbiMNi R2GA== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=list-unsubscribe-post:list-unsubscribe:content-transfer-encoding :mime-version:subject:message-id:to:reply-to:from:date :dkim-signature:dkim-signature; bh=lRbjhPaWWcqbqU9N+oPTIcQ4mD7n89lSSiAhbGE60Ds=; fh=T+1cAzDwU59AOoRV42gQlbZgZr40o0M3jf3McMmQlzQ=; b=EjKGnkBh/1fxg36ZmyDe1WY2bOThm71OPSue5naSGljpa/bg50qSHeVlKCRrqlWZX6 eTvjfsVl8t32gLLNiy/W1baFS9YIx3NVWclbLXJa0YtSl2Pe+l0Rt131ScbDU+RLjOid l7KxS64tzubRnqL1V/1EvK+OgAVCOEWayKCey2P4inENZ4CDM9dJ2kFs+ruI8v02HuYL ia6LjIuRZ2/YmReKM6Sqnh2a6oWZWUB0haHuXvZ6weciyTZHV5aGTWSIWNgdNlqfiLbK rZl+a15ea1q4u9i+n5D7hYCiID3kUq6Zermh6G5CW4MBm81bcT5si0v5maqSMRXl01zx N9Rg==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@email.jamanetwork.com header.s=class header.b=aSuqXIze; dkim=pass header.i=@email.jamanetwork.com header.s=class header.b=JraMh09O; spf=pass (google.com: domain of bounce-ndptqwpjtnrkkrnqrpdkytqdknkhyrmjjj@email.jamanetwork.com designates 74.214.206.14 as permitted sender) smtp.mailfrom=bounce-ndptqwpjtnrkkrnqrpdkytqdknkhyrmjjj@email.jamanetwork.com; dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=email.jamanetwork.com Return-Path: <bounce-ndptqwpjtnrkkrnqrpdkytqdknkhyrmjjj@email.jamanetwork.com> Received: from mail1.email.jamanetwork.com (mail1.email.jamanetwork.com. [74.214.206.14]) by mx.google.com with ESMTPS id af79cd13be357-8be56f768c3si343270585a.525.2025.12.16.15.21.07 for <copper.wang@gmail.com> (version=TLS1_3 cipher=TLS_AES_256_GCM_SHA384 bits=256/256); Tue, 16 Dec 2025 15:21:07 -0800 (PST) Received-SPF: pass (google.com: domain of bounce-ndptqwpjtnrkkrnqrpdkytqdknkhyrmjjj@email.jamanetwork.com designates 74.214.206.14 as permitted sender) client-ip=74.214.206.14; Authentication-Results: mx.google.com; dkim=pass header.i=@email.jamanetwork.com header.s=class header.b=aSuqXIze; dkim=pass header.i=@email.jamanetwork.com header.s=class header.b=JraMh09O; spf=pass (google.com: domain of bounce-ndptqwpjtnrkkrnqrpdkytqdknkhyrmjjj@email.jamanetwork.com designates 74.214.206.14 as permitted sender) smtp.mailfrom=bounce-ndptqwpjtnrkkrnqrpdkytqdknkhyrmjjj@email.jamanetwork.com; dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=email.jamanetwork.com DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; s=class; d=email.jamanetwork.com; h=Date:From:Reply-To:To:Message-ID:Subject:MIME-Version:Content-Type: Content-Transfer-Encoding:List-Unsubscribe:List-Unsubscribe-Post; i=updates@email.jamanetwork.com; bh=lRbjhPaWWcqbqU9N+oPTIcQ4mD7n89lSSiAhbGE60Ds=; b=aSuqXIzegtgQq+XiQE06hGvmiuHGZJyx1njbU6gsyW+lR07SdJDgukzUDYHRW7Ql9ZIT0UX98hvN EQpxMJVd9g72iZ8EgBhPoCIFYA/sKyzBr5gtaF2TRmoS4q6uVRlaOnUH0JPIu9pBq62W1lkIKWjT vH60a6sw52AiXZI+3Ac= DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; s=class; d=email.jamanetwork.com; h=Date:From:Reply-To:To:Message-ID:Subject:MIME-Version:Content-Type: Content-Transfer-Encoding:List-Unsubscribe:List-Unsubscribe-Post; bh=lRbjhPaWWcqbqU9N+oPTIcQ4mD7n89lSSiAhbGE60Ds=; b=JraMh09Okr1ULLFRLdAQYPNM0uiF8XdUMOf6JkIoy/Kqb3J8da+bgmfNaeIBmwjztuJiKICA2Iz8 Z4pNzgqHaJamxSiNf8IMckhq00dM4MeO8VDovLBBb2cSAa+sYmZI3sonT6/Jnfv8btpedzUn6EzU cfzDUAVE8MMRZvdTfxQ= Received: by mail1.email.jamanetwork.com id h87km6398q8a for <copper.wang@gmail.com>; Tue, 16 Dec 2025 17:21:05 -0600 (envelope-from <bounce-ndptqwpjtnrkkrnqrpdkytqdknkhyrmjjj@email.jamanetwork.com>) Date: Tue, 16 Dec 2025 17:21:05 -0600 (CST) From: JAMA <updates@email.jamanetwork.com> Reply-To: JAMA Replies <replies@admin.jamanetwork.com> To: friend <copper.wang@gmail.com> Message-ID: <1940166960.6793751.1765927265153@email.jamanetwork.com> Subject: New issue: Update to SOFA Score in Critically Ill Patients (SOFA-2), AI vs Human Coaching for Diabetes Prevention, Cutaneous Melanoma Review MIME-Version: 1.0 Content-Type: text/html; charset=UTF-8 Content-Transfer-Encoding: quoted-printable X-AMA: cpjmjdhhpcdjftdtfjpmpqqccl mrdjzqqqcrmkgmtvvczcvmprkjvclnzkfgthlqgfjmmjftjlcmdgtcm tjttpmdhqp List-Unsubscribe: <mailto:unsub-410684-7997-9D27C8885D9A491BB5C5B93DA7B56FCA@email.jamanetwork.com>,<https://click1.email.jamanetwork.com/Unsub.do?pup=hnhsvnwmszhffhzfrqhpmmmcrflsfvjjcpcjfbrlhjcwgplzc&List-Unsubscribe=One-Click> List-Unsubscribe-Post: List-Unsubscribe=One-Click <head style=3D"box-sizing: border-box"> <meta content=3D"width=3Ddevice-width" name=3D"viewport" style=3D"box-siz= ing: border-box"/> <style style=3D"box-sizing: border-box" type=3D"text/css"> .cmeLink a:hover { text-decoration: underline !important; } .cmeLink a {= color: #981B1E !important; text-decoration: none; } .cmelink { border-left= :2px solid #981B1E !important; font-size:14px !important; font-weight:bold = !important; padding-left:6px !important; color: #981B1E !important; } .addressText {color: #333; font-family: Helvetica, Arial, sans-= serif; font-size: 10px; line-height: 1.25;margin:0;text-align: left;} .alertDate {padding: 14px 0 10px 20px;font-family: Helvetica, A= rial, sans-serif; font-size: 11px; font-style: normal; font-weight: bold; l= etter-spacing: 0.5px;text-align: left; color: #981B1E !important; text-tran= sform: uppercase;} .alertType {display: block; font-family: Helvetica, Arial, sans= -serif; font-size: 24px; font-style: normal; font-weight: bold; letter-spac= ing: -1px; margin: 0px; padding: 0px; text-align: left; color: #222222 !imp= ortant;} .articleContent {margin: 10px 0 24px 0;} .articleContent ul {list-style-type: none;} .articleContent:last-of-type {margin-bottom: 50px;} .articleContent div {font-size: 12px; margin-top:6px;} .articleLink {color: #000;font-weight: bold;text-decoration: no= ne;} .articleLink:hover {color: #981B1E !important;} .articleType {border-top:1px solid #981B1E;color:#d71635;font-s= ize:12px;font-weight:bold;letter-spacing:1px;padding:8px 0 0 0 ;margin: 35p= x 0 0 0;text-transform: uppercase;} .articleType:first-of-type {margin:0;border-top:0;padding:0;} .bodyText {color: #000; font-family: Helvetica, Arial, sans-ser= if; font-size: 15px; line-height: 1.5;padding-right:30px;} .disclaimer {border-bottom: 1px solid #ccc; margin-top:10px;pad= ding: 0 20px 10px 23px;} .featuredContent {border-top:0;color:#d71635;font-size:12px;fon= t-weight:bold;letter-spacing:1px;padding:0 ;margin: 0 0 16px 0;text-transfo= rm: uppercase;} .footerCopyright {color: #333; font-family: Helvetica, Arial, s= ans-serif; font-size: 11px; line-height: 125%;margin:0;text-align: left;} .footerText {color: #333; font-family: Helvetica, Arial, sans-s= erif; font-size: 10px; margin-top:5px;text-align: left;} .lockupContent {border-bottom:1px solid #981B1E; border-top:1px= solid #981B1E; padding:15px 0;} .preHeader {display: none !important;} .readOnline {color: #555; font-family: Helvetica,Arial,sans-ser= if;font-size: 10.5px; line-height: 1em;margin: 0 !important;padding: 0 !imp= ortant;} .readOnline a {color: #0067dd;text-decoration:none;} .redesignContainer {padding:0;} .relatedArticleType { background-color: #fff; padding: 10px 0 5= px 15px; line-height: 1.5em; font-size: 12px; } .relatedArticleTypeName { font-weight: bold; margin-bottom: 0; = padding-bottom: 0; } .relatedArticleType ul { list-style-position: inside; padding-l= eft:0; padding-top: 2px; margin-top: 0; margin-bottom: 0; padding-bottom: 0= ; line-height: 1.5em; } .relatedArticleType li { padding-bottom: 5px; } .relatedArticleName { font-size: 12px !important; line-height: = 1.5em; } .relatedArticleName a { font-size: 12px !important; line-height= : 1.5em; } .rightColumnText {color: #333; font-family: Helvetica,Arial,san= s-serif;font-size: 12px; line-height: 1.5em;margin: 0 !important;padding: 0= !important;} .rightColumnLink:hover {color:#981B1E !important;} .signatureContent {border-bottom:1px solid #981B1E; border-top:= 1px solid #981B1E; margin-bottom:10px; margin-top:15px;padding:15px 0;} #socialIcons {vertical-align: middle; padding-top: 7px;} .superClassification {font-weight:bold;} .unsubText {color: #333; font-family: Helvetica, Arial, sans-se= rif; font-size: 10px; line-height: 1.85;margin:10px 0 0 0;text-align: left;= } @media only screen and (max-width: 480px) { .alertDate {padding: 13px 0 12px 20px !important; font-size: 10= px !important;} .alertType {font-size: 16px !important;} .articleContent div {font-size: 12px;} .articleLink {font-size:17px !important;} .footerText {font-size: 11px;} .journalNameCell {padding-top:15px !important;} .onlineFirstOptional {font-size:13px;} .promoImage {display: none !important;width: 100%!important;} .redesignContainer {padding:0 !important;} .lockupPadding {padding-bottom:35px !important;} body, table, td, p, a, li, blockquote {-webkit-text-size-adjust= :none !important;} table[id=3D"templateContainer"] {width:100% !important;max-widt= h:600px !important;} table[class=3D"bannerTable"] {max-width:600px !important;width:= 100% !important;} table[id=3D"bodyTable"] {width:100%!important;max-width:600px!i= mportant;} table[class=3D"alertContentTable"] {width:100%!important;max-wi= dth:420px!important;} table[class=3D"rightColumn"] {width:100%!important;max-width:42= 0px!important;} img[class=3D"rightColumnImage"] {width: 100%!important;} img[class=3D"journalName"] {height: 32px !important;width:auto= ;} td[id=3D"socialIcons"] {display: none !important;} td[class=3D"bodyText"] {padding-right:0 !important;} p[class=3D"rightColumnText"] {font-size: 14px !important;} th[class=3D"sectionContainer"] {display: block !important;heigh= t:auto !important;max-width: 600px !important;padding-left: 0;width: 100% != important;} } * {box-sizing: border-box;} .articleContent.with-image {background: #f3f3f3;border: 1px sol= id #ccc;padding: 15px;width: 100%;} .articleContent.with-image .relatedArticleType {background-colo= r: #f3f3f3 !important;} a.image-link img {width:100%;max-width:100%;padding-bottom: 9px= !important;} img.article-image {width: 100%;max-width: 100%;padding-bottom: = 9px !important;} </style> <style style=3D"box-sizing: border-box" type=3D"text/css"> .c1-ui-state-hover {background-color:yellow !important; padding:5px !imp= ortant } </style> </head> <body style=3D"box-sizing: border-box"><div style=3D"display:none !importa= nt; opacity:0; color:transparent; mso-hide:all; max-height:0px; overflow:hi= dden;">Is reduced arsenic exposure associated with reduced chronic disease = mortality? ‌ ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌ &z= wnj; ‌ ‌ ‌ ‌ ‌ &zwnj= ; ‌ ‌ ‌ ‌ ‌ ‌&n= bsp;‌ ‌ ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌ &z= wnj; ‌ ‌ ‌ ‌ ‌ &zwnj= ; ‌ ‌ ‌ ‌ ‌ ‌&n= bsp;‌ ‌ ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌ &z= wnj; ‌ ‌ ‌ ‌ ‌ &zwnj= ; ‌ ‌ ‌ ‌ ‌ ‌&n= bsp;‌ ‌ ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌ &z= wnj; ‌ ‌ ‌ ‌ ‌ &zwnj= ; ‌ ‌ ‌ ‌ ‌ ‌&n= bsp;‌ ‌ ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌ &z= wnj; ‌ ‌ ‌ ‌ ‌ &zwnj= ; ‌ ‌ ‌ ‌ ‌ ‌&n= bsp;‌ ‌ ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌ &z= wnj; ‌ ‌ ‌ ‌ ‌ &zwnj= ; ‌ ‌ ‌ ‌ ‌ ‌&n= bsp;‌ ‌ ‌ ‌ ‌ ‌ = ;‌ </div><img src=3D"https://d7f2e3.www.efeedbacktrk.com/qpmdqwpr= hhhtgqdjtvdmytygrgtydsqjpygfbrjmdsnhf_blfjpdqbjypcqgzljpgz.gif" width=3D"0"= height=3D"0" alt=3D""> <span class=3D"preheader" id=3D"email_" name=3D"email_" style=3D"box-sizi= ng: border-box;font-size: 1px;color: #f2f2f2;display: none"> Read the latest research from JAMA, which provides readers throughout th= e world with essential medical information and a unique forum for discussio= ns shaping the future of medical practice and public health. </span> <table align=3D"center" bgcolor=3D"#ffffff" border=3D"0" cellpadding=3D"1= 5" cellspacing=3D"0" style=3D"box-sizing: border-box" width=3D"100%"> <tbody style=3D"box-sizing: border-box"> <tr style=3D"box-sizing: border-box"> <td style=3D"box-sizing: border-box;text-align: center"> <p class=3D"readOnline" style=3D"box-sizing: border-box;color: #33333= 3;font-family: Helvetica, Arial, sans-serif;font-size: 11px;line-height: 1e= m;margin: 0px !important;padding: 0px !important"> Trouble viewing this email? <span c2f=3D"true" contenteditable=3D"true" id=3D"1" name=3D" Campai= gn ViewOnlineURL " type=3D"LINK"> <a href=3D"https://click1.email.jamanetwork.com/ViewMessage.do?m=3D= xgpjccj&r=3Drnckcjvwk&s=3Dezpqlszwpppblqvtqrjjbwbjqylvzjbhkwv&q=3D176592415= 9&a=3Dview" id=3D"auto_assign_link_num_236" name=3D" Campaign ViewOnlineURL= " style=3D"box-sizing: border-box;color: #0067dd;text-decoration: none"> Read it Online </a> </span> </p> </td> </tr> <tr style=3D"box-sizing: border-box"> <td style=3D"box-sizing: border-box"> <table align=3D"center" bgcolor=3D"#ffffff" border=3D"0" cellpadding= =3D"0" cellspacing=3D"0" id=3D"templateContainer" style=3D"box-sizing: bord= er-box" width=3D"720"> <tbody style=3D"box-sizing: border-box"> <tr style=3D"box-sizing: border-box"> <td colspan=3D"2" style=3D"box-sizing: border-box;max-width: 720px= " valign=3D"top"> <table border=3D"0" cellpadding=3D"0" cellspacing=3D"0" class=3D"= bannerTable" style=3D"box-sizing: border-box" width=3D"100%"> <tbody style=3D"box-sizing: border-box"> <!-- Top Banner Ad --> <tr> <td style=3D"font-family:Arial, Helvetica, sans-serif"> <a href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193089:410684:9= D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159&a=3D410684&b=3D410684&c=3D" = target=3D"_blank" style=3D"box-sizing: border-box;"> <img style=3D"box-sizing: border-box;border-width: 0px;border-style: so= lid; max-height:100px; " width=3D"100%" src=3D"https://static.adsugar.ch/im= g?ord=3D410684&c=3D410684&iu=3D/6479/ama.jama/newsletter_etoc&t=3Dpos%3Dtop= %26date%3D120125h&sz=3D728x90" alt=3D"Alt content" /> </a> <!-- --> </td> </tr> <tr><td style=3D"text-align: center; "> <small style=3D"box-sizing: border-box;"> <img class=3D"disclaimer" alt=3D"Advertisement" src=3D"https://cdn.jamane= twork.com/ImageLibrary/ads/advertise_disclaimer.PNG"=20 style=3D"box-sizing: border-box;border-bottom: 1px solid #ccc;margin-top= : 10px;padding: 0 20px 10px 23px;" /> </small> </td></tr> </tbody> </table> </td> </tr> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - // nameplate row starts here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <tr> <td align=3D"left" style=3D"padding:20px 0 10px;" widt= h=3D"100%"> <img width=3D"89" src=3D"https://cdn.jamanetwork.co= m/ImageLibrary/etocs/jamalogo.png" style=3D"display:block;height:auto;borde= r:0;"> </td> </tr> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - // nameplate row ends here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - // lockup row starts here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <tr style=3D"box-sizing: border-box"> <td class=3D"redesignContainer lockupPadding" colspan=3D"2" style= =3D"box-sizing: border-box;padding: 0;max-width: 720px;padding-bottom: 35px= "> <table border=3D"0" cellpadding=3D"0" cellspacing=3D"0" class=3D"= lockupContent" style=3D"box-sizing: border-box;border-bottom: 1px solid #98= 1B1E;border-top: 1px solid #981B1E;padding: 15px 0" width=3D"100%"> <tbody style=3D"box-sizing: border-box"> <tr style=3D"box-sizing: border-box"> <td style=3D"box-sizing: border-box" valign=3D"bottom"> <table align=3D"left" border=3D"0" cellpadding=3D"0" cellspac= ing=3D"0" style=3D"box-sizing: border-box"> <tbody style=3D"box-sizing: border-box"> <tr style=3D"box-sizing: border-box"> <td style=3D"box-sizing: border-box;border-right: 1px soli= d #981B1E;padding: 10px 20px 10px 0"> <p class=3D"alertType" style=3D"box-sizing: border-box;di= splay: block;font-family: Helvetica, Arial, sans-serif;font-size: 24px;font= -style: normal;font-weight: bold;letter-spacing: -1px;margin: 0px;padding: = 0px;text-align: left;color: #222222 !important"> <strong style=3D"box-sizing: border-box"> New Issue </strong> </p> </td> <td class=3D"alertDate" style=3D"box-sizing: border-box;pa= dding: 10px 0 10px 20px;font-family: Helvetica, Arial, sans-serif;font-size= : 11px;font-style: normal;font-weight: bold;letter-spacing: 0.5px;text-alig= n: left;color: #981B1E !important;text-transform: uppercase"> December 16, 2025; Volume 334, Number 23 </td> </tr> </tbody> </table> <table align=3D"right" border=3D"0" cellpadding=3D"0" cellspa= cing=3D"0" style=3D"box-sizing: border-box"> <tbody style=3D"box-sizing: border-box"> <tr style=3D"box-sizing: border-box;"> <td style=3D"box-sizing: border-box;vertical-align: middle;padding-= top: 7px;" id=3D"socialIcons"> <a href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193090:= 410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D"box-sizin= g: border-box;"><img class=3D"2017-email-icon" alt=3D"facebook icon" src=3D= "https://cdn.jamanetwork.com/ImageLibrary/etocs/2017-email-icon-facebook.pn= g" width=3D"31" style=3D"box-sizing: border-box;" /></a> <a href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193091:= 410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D"box-sizing= : border-box;"><img class=3D"2017-email-icon" alt=3D"twitter icon" src=3D"h= ttps://cdn.jamanetwork.com/ImageLibrary/etocs/2017-email-icon-twitter.png" = width=3D"31" style=3D"box-sizing: border-box;" /></a> <a href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193092:= 410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D"box-sizin= g: border-box;"><img class=3D"2017-email-icon" alt=3D"linked in icon" src= =3D"https://cdn.jamanetwork.com/ImageLibrary/etocs/2017-email-icon-linkedin= .png" width=3D"31" style=3D"box-sizing: border-box;" /></a> <a href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193093:= 410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D"box-sizin= g: border-box;"><img class=3D"2017-email-icon" alt=3D"pinterest icon" src= =3D"https://cdn.jamanetwork.com/ImageLibrary/etocs/2017-email-icon-pinteres= t.png" width=3D"31" style=3D"box-sizing: border-box;" /></a> <a href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193094:= 410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D"box-sizing= : border-box;"><img class=3D"2017-email-icon" alt=3D"youtube icon" src=3D"h= ttps://cdn.jamanetwork.com/ImageLibrary/etocs/2017-email-icon-youtube.png" = width=3D"31" style=3D"box-sizing: border-box;" /></a> <a href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193095:= 410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D"box-sizin= g: border-box;"><img class=3D"2017-email-icon" alt=3D"instagram icon" src= =3D"https://cdn.jamanetwork.com/ImageLibrary/etocs/2020-email-icon-instagra= m.png" width=3D"31" style=3D"box-sizing: border-box;" /></a> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - // lockup row ends here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - // optional row starts here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <!-- <tr> <td class=3D"bodyText" colspan=3D"2" valig= n=3D"top" style=3D"max-width:720px;padding-bottom:35px;"> <p class=3D"onlineFirstOptional">This a= rticle is being published online first [due to / to coincide with] [public = heath / conference name].</p> </td> </tr> --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - // optional row ends here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - // alert content starts here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <tr style=3D"box-sizing: border-box"> <td class=3D"redesignContainer" style=3D"box-sizing: border-box;pa= dding: 0;max-width: 720px" valign=3D"top"> <table border=3D"0" cellpadding=3D"0" cellspacing=3D"0" id=3D"bod= yTable" style=3D"box-sizing: border-box" width=3D"100%"> <tbody style=3D"box-sizing: border-box"> <tr style=3D"box-sizing: border-box"> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - // left column starts here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <th align=3D"left" class=3D"sectionContainer" style=3D"box-siz= ing: border-box;font-weight: normal" valign=3D"top" width=3D"490"> <table align=3D"left" border=3D"0" cellpadding=3D"0" cellspac= ing=3D"0" class=3D"alertContentTable" style=3D"box-sizing: border-box" vali= gn=3D"top" width=3D"490"> <tbody style=3D"box-sizing: border-box"> <tr style=3D"box-sizing: border-box"> <td class=3D"bodyText" style=3D"box-sizing: border-box;col= or: #000;font-family: Helvetica, Arial, sans-serif;font-size: 15px;line-hei= ght: 1.5;padding-right: 30px" valign=3D"top"> <!-- articles-start --> <div class=3D"articleType" style=3D'margin:0;border-top:0= ;padding:0;'> <strong> This Week in JAMA </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193096:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Audio Highlights </a> </strong> <div class=3D"relatedArticleType"> =20 <span class=3D"relatedArticleName"> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D"https://click1.email.jamanetwork.c= om/t.do?id=3D193097:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159"= > Lung Cancer Screening Benefits, Peripheral Neuropathy= Review, Arsenic Exposure and Mortality, and more</a> </span> </div> </div> <div class=3D"articleType" > <strong> Original Investigation </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <div class=3D"superClassification"> AI in Medicine </div> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193098:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> An AI-Powered Lifestyle Intervention vs Human Coachin= g in the Diabetes Prevention Program: A Randomized Clinical Trial </a> </strong> <div class=3D"articleAuthors"> Nestoras=C2=A0Mathioudakis,=C2=A0MD, MHS; Benjamin=C2= =A0Lalani,=C2=A0BS; Mohammed S.=C2=A0Abusamaan,=C2=A0MD, MPH; et al. </div> <div class=3D"cmeLink"> <a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193099:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159"> Earn CME credit </a> </div> <div class=3D"relatedArticleType"> <span class=3D"relatedArticleTypeName"> Editorial: </span> =20 <span class=3D"relatedArticleName"> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D"https://cl= ick1.email.jamanetwork.com/t.do?id=3D193100:410684:9D27C888-5D9A-491B-B5C5-= B93DA7B56FCA:1765924159"> Artificial Intelligence and Diabetes Prevention</a>; = Leigh=C2=A0Perreault,=C2=A0MD </span> </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <div class=3D"superClassification"> Caring for the Critically Ill Patient </div> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193101:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Development and Validation of the Sequential Organ Fa= ilure Assessment (SOFA)-2 Score </a> </strong> <div class=3D"articleAuthors"> Otavio T.=C2=A0Ranzani,=C2=A0MD, MSc, PhD; Mervyn=C2=A0= Singer,=C2=A0MD; Jorge I. F.=C2=A0Salluh,=C2=A0MD, PhD; et al. </div> <div class=3D"cmeLink"> <a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193102:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159"> Earn CME credit </a> </div> <div class=3D"relatedArticleType"> <span class=3D"relatedArticleTypeName"> Audio: </span> <span class=3D"relatedArticleName"> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D"https://click1.email.jamanetwork.c= om/t.do?id=3D193103:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159"= > The Sequential Organ Failure Assessment (SOFA)-2 Scor= e</a> </span> </div> <div class=3D"relatedArticleType"> <span class=3D"relatedArticleTypeName"> Editorial: </span> =20 <span class=3D"relatedArticleName"> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D"https://cl= ick1.email.jamanetwork.com/t.do?id=3D193104:410684:9D27C888-5D9A-491B-B5C5-= B93DA7B56FCA:1765924159"> A Revision to Organ Failure Assessment in Critically = Ill Patients</a>; Christopher W.=C2=A0Seymour,=C2=A0MD, MSc </span> </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193105:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Arsenic Exposure Reduction and Chronic Disease Mortal= ity </a> </strong> <div class=3D"articleAuthors"> Fen=C2=A0Wu,=C2=A0PhD; Alexander=C2=A0van Geen,=C2=A0Ph= D; Joseph=C2=A0Graziano,=C2=A0PhD; et al. </div> </div> <div class=3D"articleType" > <strong> Research Letter </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193106:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Tracking County-Level Measles Cases in the US </a> </strong> <div class=3D"articleAuthors"> Farzin=C2=A0Ahmadi,=C2=A0PhD; Ensheng=C2=A0Dong,=C2=A0P= hD; Lauren M.=C2=A0Gardner,=C2=A0PhD </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193107:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Emergency Medicaid Spending for Undocumented Immigran= ts in the US </a> </strong> <div class=3D"articleAuthors"> Patricia Mae G.=C2=A0Santos,=C2=A0MD, MS; Kelsey=C2=A0C= halmers,=C2=A0PhD; Fumiko=C2=A0Chino,=C2=A0MD; et al. </div> </div> <div class=3D"articleType" > <strong> Viewpoint </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193108:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Advisory Committee on Immunization Practices Standard= s for Assessing Evidence </a> </strong> <div class=3D"articleAuthors"> Doug=C2=A0Campos-Outcalt,=C2=A0MD, MPA; Jonathan=C2=A0T= emte,=C2=A0MD, PhD </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <div class=3D"superClassification"> Women's Health </div> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193109:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> State Mifepristone Regulation Following <i>GenBioPro = v Raynes</i> </a> </strong> <div class=3D"articleAuthors"> Greer=C2=A0Donley,=C2=A0JD; Lewis A.=C2=A0Grossman,=C2= =A0PhD, JD; Patricia J.=C2=A0Zettler,=C2=A0JD </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193110:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Evolving Hospital-at-Home to Meet the Needs of Childr= en </a> </strong> <div class=3D"articleAuthors"> Emma=C2=A0Gerstenzang,=C2=A0MD; Aditi=C2=A0Vasan,=C2=A0= MD, MSHP; Austin S.=C2=A0Kilaru,=C2=A0MD, MSHP </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193111:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> The Make America Healthy Again Strategy Report </a> </strong> <div class=3D"articleAuthors"> Peter=C2=A0Lurie,=C2=A0MD, MPH; Lawrence O.=C2=A0Gostin= ,=C2=A0JD </div> </div> <div class=3D"articleType" > <strong> A Piece of My Mind </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193112:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> The Last Night </a> </strong> <div class=3D"articleAuthors"> Lenore M.=C2=A0Buckley,=C2=A0MD, MPH </div> </div> <div class=3D"articleType" > <strong> Editorial </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <div class=3D"superClassification"> AI in Medicine </div> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193113:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Artificial Intelligence and Diabetes Prevention </a> </strong> <div class=3D"articleAuthors"> Leigh=C2=A0Perreault,=C2=A0MD </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193114:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> A Revision to Organ Failure Assessment in Critically = Ill Patients </a> </strong> <div class=3D"articleAuthors"> Christopher W.=C2=A0Seymour,=C2=A0MD, MSc </div> </div> <div class=3D"articleType" > <strong> Review </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193115:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Cutaneous Melanoma: A Review </a> </strong> <div class=3D"articleAuthors"> Urvashi Mitbander=C2=A0Joshi,=C2=A0MD; Mohammed=C2=A0Ka= shani-Sabet,=C2=A0MD; John M.=C2=A0Kirkwood,=C2=A0MD </div> <div class=3D"cmeLink"> <a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193116:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159"> Earn CME credit </a> </div> <div class=3D"relatedArticleType"> <span class=3D"relatedArticleTypeName"> Audio: </span> <span class=3D"relatedArticleName"> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D"https://click1.email.jamanetwork.c= om/t.do?id=3D193117:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159"= > Diagnosis and Management of Cutaneous Melanoma</a> </span> </div> </div> <div class=3D"articleType" > <strong> JAMA Guide to Statistics and Methods </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193118:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Pattern-Mixture Models for Missing Data </a> </strong> <div class=3D"articleAuthors"> Roderick J.=C2=A0Little,=C2=A0PhD </div> <div class=3D"cmeLink"> <a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193119:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159"> Earn CME credit </a> </div> </div> <div class=3D"articleType" > <strong> JAMA Insights </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193120:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Recurrent <i>Clostridioides difficile</i> Infections </a> </strong> <div class=3D"articleAuthors"> Joffrey=C2=A0van Prehn,=C2=A0MD, PhD; Ed J.=C2=A0Kuijpe= r,=C2=A0MD, PhD; Erik R.=C2=A0Dubberke,=C2=A0MD, MSPH </div> <div class=3D"cmeLink"> <a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193121:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159"> Earn CME credit </a> </div> </div> <div class=3D"articleType" > <strong> Editor's Note </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <div class=3D"superClassification"> AI in Medicine </div> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193122:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> AI in the Lab=E2=80=94Will It Really Change Drug Disc= overy? </a> </strong> <div class=3D"articleAuthors"> Roy=C2=A0Perlis,=C2=A0MD, MSc </div> <div class=3D"relatedArticleType"> <span class=3D"relatedArticleTypeName"> Audio: </span> <span class=3D"relatedArticleName"> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D"https://click1.email.jamanetwork.c= om/t.do?id=3D193123:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159"= > AI for Drug Discovery</a> </span> </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193124:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> =E2=80=9CHow Strangely Sweet=E2=80=9D: Laryngitis and= the Quiet Quirkiness of Senryu </a> </strong> <div class=3D"articleAuthors"> Rafael=C2=A0Campo,=C2=A0MD, MA </div> </div> <div class=3D"articleType" > <strong> Medical News </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193125:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> New Insights on Circadian Health and Cardiometabolic = Disease=E2=80=94Light, Sleep, Food, Exercise, and More </a> </strong> <div class=3D"articleAuthors"> Kate=C2=A0Schweitzer </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <div class=3D"superClassification"> Quick Uptakes </div> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193126:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Gluten Sensitivity Is Common Around the World=E2=80= =94Explanations Are Emerging </a> </strong> <div class=3D"articleAuthors"> Samantha=C2=A0Anderer </div> </div> <div class=3D"articleType" > <strong> Medical News in Brief </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193127:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> 2024-2025 COVID-19 Vaccines Protected Against JN.1 Su= bvariants </a> </strong> <div class=3D"articleAuthors"> Shravya=C2=A0Pant </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193128:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> FDA Approves Nonhormonal Treatment for Menopausal Hot= Flashes </a> </strong> <div class=3D"articleAuthors"> Shravya=C2=A0Pant </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193129:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Meta-Analysis: Viral Infections May Raise Cardiovascu= lar Risks </a> </strong> <div class=3D"articleAuthors"> Shravya=C2=A0Pant </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193130:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Bacterial Vaginosis Treatment Should Involve All Part= ners, ACOG Says </a> </strong> <div class=3D"articleAuthors"> Shravya=C2=A0Pant </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193131:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Updated Flu, RSV Vaccination Recommendations for Immu= nocompromised People </a> </strong> <div class=3D"articleAuthors"> Shravya=C2=A0Pant </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193132:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> AAP: Leucovorin Not Recommended for Autism </a> </strong> <div class=3D"articleAuthors"> Shravya=C2=A0Pant </div> </div> <div class=3D"articleType" > <strong> Poetry and Medicine </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193133:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Hush </a> </strong> <div class=3D"articleAuthors"> John=C2=A0Savoie,=C2=A0PhD </div> <div class=3D"relatedArticleType"> <span class=3D"relatedArticleTypeName"> Editor's Note: </span> =20 <span class=3D"relatedArticleName"> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D"https://cl= ick1.email.jamanetwork.com/t.do?id=3D193134:410684:9D27C888-5D9A-491B-B5C5-= B93DA7B56FCA:1765924159"> =E2=80=9CHow Strangely Sweet=E2=80=9D: Laryngitis and= the Quiet Quirkiness of Senryu</a>; Rafael=C2=A0Campo,=C2=A0MD, MA </span> </div> </div> <div class=3D"articleType" > <strong> JAMA Revisited </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193135:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Sunshine and Health </a> </strong> </div> <div class=3D"articleType" > <strong> JAMA Patient Page </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193136:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Early-Onset Gastrointestinal Cancer </a> </strong> <div class=3D"articleAuthors"> Krista=C2=A0Roberts,=C2=A0MD </div> </div> <div class=3D"articleType" > <strong> Audio </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193137:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Lung Cancer Screening Benefits, Peripheral Neuropathy= Review, Arsenic Exposure and Mortality, and more </a> </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193138:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> The Sequential Organ Failure Assessment (SOFA)-2 Scor= e </a> </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193139:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Diagnosis and Management of Cutaneous Melanoma </a> </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193140:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> AI for Drug Discovery </a> </strong> </div> <div class=3D"articleType" > <strong> Comment & Response </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193141:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Telehealth and Online Cognitive Behavioral Therapy=E2= =80=93Based Treatments for High-Impact Chronic Pain </a> </strong> <div class=3D"articleAuthors"> Yilin=C2=A0Jiang,=C2=A0PhD; Narina A.=C2=A0Samah,=C2=A0= PhD; Heng=C2=A0Zhou,=C2=A0MSc </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193142:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Telehealth and Online Cognitive Behavioral Therapy=E2= =80=93Based Treatments for High-Impact Chronic Pain </a> </strong> <div class=3D"articleAuthors"> Dandan=C2=A0Xu,=C2=A0MM; Ran=C2=A0Chen,=C2=A0MD; Hongji= an=C2=A0Shan,=C2=A0MD </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193143:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Telehealth and Online Cognitive Behavioral Therapy=E2= =80=93Based Treatments for High-Impact Chronic Pain=E2=80=94Reply </a> </strong> <div class=3D"articleAuthors"> Lynn L.=C2=A0DeBar,=C2=A0PhD, MPH; Andrea J.=C2=A0Cook,= =C2=A0PhD; Francis J.=C2=A0Keefe,=C2=A0PhD </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193144:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Review on Uveitis </a> </strong> <div class=3D"articleAuthors"> Steven=C2=A0Oscherwitz,=C2=A0MD </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193145:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Review on Uveitis=E2=80=94Reply </a> </strong> <div class=3D"articleAuthors"> Panayiotis=C2=A0Maghsoudlou,=C2=A0PhD; Andrew D.=C2=A0D= ick,=C2=A0MD </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193146:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Lower Urinary Tract Symptoms in Males </a> </strong> <div class=3D"articleAuthors"> Zhigui=C2=A0Zheng,=C2=A0MD; Xinxin=C2=A0Jiang,=C2=A0MD;= Binbin=C2=A0Wu,=C2=A0MD </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193147:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Lower Urinary Tract Symptoms in Males </a> </strong> <div class=3D"articleAuthors"> Sanjay=C2=A0Sinha,=C2=A0MCh; Pawan=C2=A0Vasudeva,=C2=A0= MCh </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193148:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Lower Urinary Tract Symptoms in Males </a> </strong> <div class=3D"articleAuthors"> Jean-Nicolas=C2=A0Cornu,=C2=A0MD, PhD; Benoit=C2=A0Peyr= onnet,=C2=A0MD, PhD; Cosimo=C2=A0De Nunzio,=C2=A0MD, PhD </div> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193149:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> Lower Urinary Tract Symptoms in Males=E2=80=94Reply </a> </strong> <div class=3D"articleAuthors"> John T.=C2=A0Wei,=C2=A0MD, MS; Casey=C2=A0Dauw,=C2=A0MD= ; Casey=C2=A0Brodsky,=C2=A0MD, PhD </div> </div> <div class=3D"articleType" > <strong> JAMA Masthead </strong> </div> <div class=3D"articleContent" style=3D"margin: 10px 0 24p= x 0;"> <strong> <!-- apply TLF processing --> <a class=3D"articleLink" style=3D"color: #000;font-weig= ht: bold;text-decoration: none;" href=3D'https://clic= k1.email.jamanetwork.com/t.do?id=3D193150:410684:9D27C888-5D9A-491B-B5C5-B9= 3DA7B56FCA:1765924159'> JAMA </a> </strong> </div> </td> </tr> </tbody> </table> </th> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - // left column ends here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <!--start template rr--> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - // RIGHT COLUMN starts here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - [AAA-DO NOT REMOVE] - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - [CODE START-WORK BELOW THIS LINE] --> <th align=3D"left" class=3D"secti= onContainer" style=3D"box-sizing: border-box;font-weight: normal;" valign= =3D"top" width=3D"202"> <!--START_TEMPLATE_RIGHTRAIL--> <table align=3D"right" border= =3D"0" cellpadding=3D"0" cellspacing=3D"0" class=3D"rightColumn" width=3D"2= 00"> <tbody> <tr> <td valign=3D"top"> <table border=3D"0"= cellpadding=3D"0" cellspacing=3D"0"> <tbody> </tbody> <tbody> <tr> <td class=3D"p50-0" align=3D"center"> <a style=3D"color: #000;font-size:12px;font-weight: normal;text-dec= oration: none;font-family:Arial, Helvetica, sans-serif" href=3D"h= ttps://click1.email.jamanetwork.com/t.do?id=3D193151:410684:9D27C888-5D9A-4= 91B-B5C5-B93DA7B56FCA:1765924159" valign=3D"top" target=3D"_blank"> <img alt=3D"" style=3D"display:block;height:auto;border:0;" src= =3D"https://cdn.jamanetwork.com/ImageLibrary/MarketingImages/RightRail/Inst= agram-Right-Rail-200x200.png" class=3D"full_img" width=3D"190"> <br>Be part of the story. Follow JAMA Network on Instagram. </a> </td> </tr> <!--- - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - // right column block 1 ends here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - // right column block 2 starts here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <!-- <tr> <td> <a href= =3D"https://click1.email.jamanetwork.com/t.do?id=3D193152:410684:9D27C888-5= D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D"color: #000;font-weight: no= rmal;text-decoration: none;" class=3D"articleLink" id=3D"auto_assign_link_n= um_228" name=3D"https jamanetwork journals jama fullarticle 3"> <img al= t=3D"" src=3D"https://jamanetwork.com/ImageLibrary/jama/2019/190917-etoc-al= ert-450-2.jpg" style=3D"border: 1px solid #999999;" class=3D"rightColumnIma= ge" width=3D"200" /> </a> </td> </tr> <tr> <td sty= le=3D"padding: 10px 0px 30px; text-align: left; line-height: 150%;"> <p styl= e=3D"color: #333;font-family: Helvetica,Arial,sans-serif;font-size: 12px;li= ne-height: 1.5em;margin: 0 !important;padding: 0 !important;padding-bottom:= 10px !important;" class=3D"rightColumnText">Author Interview: <a vali= gn=3D"top" href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193153:41= 0684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D"color: #000;= font-weight:normal; text-decoration: none;" class=3D"rightColumnLink" id=3D= "auto_assign_link_num_229" name=3D"https jamanetwork journals jama fullar= ticle 4">Management of Heart Failure in 2019-2020, Part 1 </a> </p> <p clas= s=3D"rightColumnText" style=3D"color: #333;font-family: Helvetica,Arial,san= s-serif;font-size: 12px;line-height: 1.5em;margin: 0 !important;padding: 0 = !important;">Author Interview: <a clas= s=3D"rightColumnLink" style=3D"color: #000;font-weight:normal; text-decorat= ion: none;" href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193154:4= 10684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" valign=3D"top" id=3D= "auto_assign_link_num_251" name=3D"https itunes apple us app jn listen au= dio c">Management of Heart Failure in 2019-2020, Part 2 </a> </p> </td> </tr> --> <!--- - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - // right column block 2 ends here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - // rightRail promo 3 starts here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <!-- <tr> <td> <a clas= s=3D"articleLink" style=3D"color: #000;font-weight: normal;text-decoration:= none;" href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193155:41068= 4:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" id=3D"auto_assign_link_n= um_250" name=3D"https itunes apple us app jn listen audio c"> <img al= t=3D"" class=3D"rightColumnImage" style=3D"border: 1px solid #999999;" src= =3D"https://jamanetwork.com/ImageLibrary/jama/2019/191217-jama-etoc-alert-4= 50-2.jpg" width=3D"200" /> </a> </td> </tr> <tr> <td sty= le=3D"padding: 10px 0px 30px; text-align: left; line-height: 150%;"> <p clas= s=3D"rightColumnText" style=3D"color: #333;font-family: Helvetica,Arial,san= s-serif;font-size: 12px;line-height: 1.5em;margin: 0 !important;padding: 0 = !important;">Audio Clinical Review: <a clas= s=3D"rightColumnLink" style=3D"color: #000;font-weight:normal; text-decorat= ion: none;" href=3D"https://click1.email.jamanetwork.com/t.do?id=3D193156:4= 10684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" valign=3D"top" id=3D= "auto_assign_link_num_251" name=3D"https itunes apple us app jn listen au= dio c 2">The Underappreciated Problem of Cardiac Disease in Women </a> </p> </td> </tr> --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - // rightRail promo 3 ends here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> </tbody> </table> </td> </tr> </tbody> </table> </th> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - [CODE END-WORK ABOVE THIS LINE] --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - [AAA-DO NOT REMOVE] --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - * - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - --> <!-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - // RIGHT COLUMN ends here // * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -= * - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - = * - - - - - - - - - - - - - - - - - - --> <!--end template rr--> </tr> </tbody> </table> </td> </tr> <tr style=3D"box-sizing: border-box"> <td class=3D"redesignContainer" colspan=3D"2" style=3D"box-sizing:= border-box;padding: 0;max-width: 720px"> <table border=3D"0" cellpadding=3D"0" cellspacing=3D"0" class=3D"= signatureContent" style=3D"box-sizing: border-box;border-bottom: 1px solid = #981B1E;border-top: 1px solid #981B1E;margin-bottom: 10px;margin-top: 15px;= padding: 15px 0" width=3D"100%"> <tbody style=3D"box-sizing: border-box"> <tr style=3D"box-sizing: border-box"> <td style=3D"box-sizing: border-box" valign=3D"bottom"> <table align=3D"left" border=3D"0" cellpadding=3D"0" cellspac= ing=3D"0" style=3D"box-sizing: border-box"> <tbody style=3D"box-sizing: border-box"> <tr style=3D"box-sizing: border-box"> <td style=3D"box-sizing: border-box;padding: 10px 0"> <img alt=3D"JAMA Network signature " class=3D"networkName= " height=3D"42" src=3D"https://cdn.jamanetwork.com/ImageLibrary/etocs/jn-si= g-jama-42px.png" style=3D"box-sizing: border-box;border-width: 0px;border-s= tyle: solid"/> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> <tr style=3D"box-sizing: border-box"> <td class=3D"redesignContainer" colspan=3D"2" style=3D"box-sizing:= border-box;padding: 0;max-width: 720px" valign=3D"top"> <table align=3D"center" border=3D"0" cellpadding=3D"0" cellspacin= g=3D"0" style=3D"box-sizing: border-box" width=3D"100%"> <tbody style=3D"box-sizing: border-box"> <tr style=3D"box-sizing: border-box"> <td style=3D"box-sizing: border-box" valign=3D"top"> <p class=3D"footerText" style=3D"box-sizing: border-box;color= : #333;font-family: Helvetica, Arial, sans-serif;font-size: 10px;margin-top= : 5px;text-align: left"> Thank you for subscribing to JAMA Network email alerts. This= message was sent to <span style=3D"box-sizing: border-box;text-decoration: none= ;color: #1a0db4;font-weight: bold"> copper.wang@gmail.com </span> by <a href=3D"mailto:updates@email.jamanetwork.com" style=3D"bo= x-sizing: border-box;text-decoration: none;color: #1a0db4;font-weight: bold= ">updates@email.jamanetwork.com</a>. </p> <p class=3D"footerText" style=3D"box-sizing: border-box;color= : #333;font-family: Helvetica, Arial, sans-serif;font-size: 10px;margin-top= : 5px;text-align: left"> To update your contact information, change your email prefer= ences, or unsubscribe, <span c2f=3D"true" contenteditable=3D"true" type=3D"LINK"> <a href=3D"https://click1.email.jamanetwork.com/t.do?id=3D1= 93157:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159&a=3Dcopper.wan= g%40gmail.com&b=3D410684" style=3D"box-sizing: border-box;text-decoration:= none;color: #1a0db4;font-weight: bold"> click here</a>.</span> </p> <p class=3D"footerText" style=3D"box-sizing: border-box;color= : #333;font-family: Helvetica, Arial, sans-serif;font-size: 10px;margin-top= : 5px;text-align: left"> To ensure you always receive JAMA Network emails, add the em= ail address <a href=3D"mailto:updates@email.jamanetwork.com" style=3D"bo= x-sizing: border-box;text-decoration: none;color: #1a0db4;font-weight: bold= "> updates@email.jamanetwork.com</a> to your address book. </p> <p class=3D"unsubText" style=3D"box-sizing: border-box;color:= #333;font-family: Helvetica, Arial, sans-serif;font-size: 10px;line-height= : 1.85;margin: 10px 0 0 0;text-align: left"> To unsubscribe by mail, contact: </p> <p class=3D"addressText" style=3D"box-sizing: border-box;colo= r: #333;font-family: Helvetica, Arial, sans-serif;font-size: 10px;line-heig= ht: 1.25;margin: 0;text-align: left"> JAMA Network <br style=3D"box-sizing: border-box"/> AMA Plaza <br style=3D"box-sizing: border-box"/> 330 N Wabash Ave <br style=3D"box-sizing: border-box"/> Chicago, IL 60611 <br style=3D"box-sizing: border-box"/> Or call (800) 621-8335. </p> </td> </tr> =09=09=09 <tr style=3D"box-sizing: border-box"> =09=09=09=09=09<td style=3D"box-sizing: border-box;vertical-align: middle;p= adding-top: 7px;" id=3D"socialIcons"> =09=09=09=09=09=09<a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193158:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D"= box-sizing: border-box;"><img class=3D"2017-email-icon" alt=3D"facebook ico= n" src=3D"https://cdn.jamanetwork.com/ImageLibrary/etocs/2017-email-icon-fa= cebook.png" width=3D"31" style=3D"box-sizing: border-box;" /></a> =09=09=09=09=09=09<a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193159:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D= "box-sizing: border-box;"><img class=3D"2017-email-icon" alt=3D"twitter ico= n" src=3D"https://cdn.jamanetwork.com/ImageLibrary/etocs/2017-email-icon-tw= itter.png" width=3D"31" style=3D"box-sizing: border-box;" /></a> =09=09=09=09=09=09<a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193160:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D= "box-sizing: border-box;"><img class=3D"2017-email-icon" alt=3D"linked in i= con" src=3D"https://cdn.jamanetwork.com/ImageLibrary/etocs/2017-email-icon-= linkedin.png" width=3D"31" style=3D"box-sizing: border-box;" /></a> =09=09=09=09=09=09<a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193161:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D= "box-sizing: border-box;"><img class=3D"2017-email-icon" alt=3D"pinterest i= con" src=3D"https://cdn.jamanetwork.com/ImageLibrary/etocs/2017-email-icon-= pinterest.png" width=3D"31" style=3D"box-sizing: border-box;" /></a> =09=09=09=09=09=09<a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193162:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D= "box-sizing: border-box;"><img class=3D"2017-email-icon" alt=3D"youtube ico= n" src=3D"https://cdn.jamanetwork.com/ImageLibrary/etocs/2017-email-icon-yo= utube.png" width=3D"31" style=3D"box-sizing: border-box;" /></a> =09=09=09=09=09=09<a href=3D"https://click1.email.jamanetwork.com/t.do?id= =3D193163:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159" style=3D= "box-sizing: border-box;"><img class=3D"2017-email-icon" alt=3D"instagram i= con" src=3D"https://cdn.jamanetwork.com/ImageLibrary/etocs/2020-email-icon-= instagram.png" width=3D"31" style=3D"box-sizing: border-box;" /></a> =09=09=09=09=09</td> =09=09=09=09</tr> <tr style=3D"box-sizing: border-box"> <td class=3D"footerCopyright" style=3D"box-sizing: border-box;= color: #333;font-family: Helvetica, Arial, sans-serif;font-size: 11px;line-= height: 125%;margin: 0;text-align: left"> <p style=3D"box-sizing: border-box;text-align: left;margin: 1= 0px 0 30px 0 !important;padding: 0px !important"> =C2=A92025 American Medical Association. All rights reserved= . <br style=3D"box-sizing: border-box"/> </p> </td> </tr> </tbody> </table> </td> </tr> <tr style=3D"box-sizing: border-box"> <td colspan=3D"2" style=3D"box-sizing: border-box;max-width: 720px= " valign=3D"top"> <table align=3D"center" border=3D"0" cellpadding=3D"0" cellspacin= g=3D"0" class=3D"bannerTable" style=3D"box-sizing: border-box" width=3D"100= %"> <tbody style=3D"box-sizing: border-box"> <!-- bottom banner ad --> <tr><td style=3D"font-family:Arial, Helvetica, sans-serif" = align=3D"center"> <a href=3D'https://click1.email.jamanetwork.com/t.do?id= =3D193164:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:1765924159'><img src= =3D"https://jamanetwork.com/ImageLibrary/MarketingImages/EmailImages/Bottom= Banners/JHF-CFP-728x90-ad-version-B.gif" width=3D"100%" class=3D"full_img" = style=3D"display:block;height:auto;border:0;"></a> </td></tr> <tr><td style=3D"font-family:Arial, Helvetica, sans-serif;f= ont-size:11px;padding:20px 0 15px 0;border-bottom" align=3D"center"><div st= yle=3D"font-family:Arial, Helvetica, sans-serif;font-size:11px;color:darkgr= ey">Advertisement</div></td></tr> </a> </span> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <!--230703--> <span style=3D"display: none;"><a href=3D'https://click1.email.jamanetwork= .com/t.do?id=3D193165:410684:9D27C888-5D9A-491B-B5C5-B93DA7B56FCA:176592415= 9&a=3D9D27C888-5D9A-491B-B5C5-B93DA7B56FCA&b=3Drnckcjvwk'>Link</a></span> <= /body> </html> === Assistant: 來源資訊 === === 來源資訊 === * 來源：JAMA（JAMA Network） * 日期：2025-12-16（Volume 334, Number 23） * 主題：New issue: Update to SOFA Score in Critically Ill Patients (SOFA-2), AI vs Human Coaching for Diabetes Prevention, Cutaneous Melanoma Review === 本期快選（最多 5 篇） === * Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score<ref>{{cite web|title=Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score|url=https://chatgpt.com/share/Development%20and%20Validation%20of%20the%20Sequential%20Organ%20Failure%20Assessment%20(SOFA|publisher=Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score|access-date=2025-12-18}}</ref>-2%20Score)｜類型：Original study｜一句導讀：330 萬 ICU 建模驗證，AUROC 0.79 優於 SOFA 0.77，重症分層可更新。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/fullarticle/2840822|publisher=JAMA Network|access-date=2025-12-18}}</ref> * An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial<ref>{{cite web|title=An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial|url=https://chatgpt.com/share/An%20AI-Powered%20Lifestyle%20Intervention%20vs%20Human%20Coaching%20in%20the%20Diabetes%20Prevention%20Program:%20A%20Randomized%20Clinical%20Trial|publisher=An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial|access-date=2025-12-18}}</ref>｜類型：Original study｜一句導讀：724 人 RCT，AI 介入複合達標不劣於人類教練（差 1.0%，95%CI −6.1～8.1）。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/fullarticle/2840703|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Arsenic Exposure Reduction and Chronic Disease Mortality<ref>{{cite web|title=Arsenic Exposure Reduction and Chronic Disease Mortality|url=https://chatgpt.com/share/Arsenic%20Exposure%20Reduction%20and%20Chronic%20Disease%20Mortality|publisher=Arsenic Exposure Reduction and Chronic Disease Mortality|access-date=2025-12-18}}</ref>｜類型：Original study｜一句導讀：尿砷每 IQR 下降 197 μg/g，慢性病死亡 aHR 0.78；高→低於中位數 aHR 0.46。 PubMed<ref>{{cite web|title=PubMed|url=https://pubmed.ncbi.nlm.nih.gov/41247717/|publisher=pubmed.ncbi.nlm.nih.gov|access-date=2025-12-18}}</ref> * Cutaneous Melanoma: A Review<ref>{{cite web|title=Cutaneous Melanoma: A Review|url=https://chatgpt.com/share/Cutaneous%20Melanoma:%20A%20Review|publisher=Cutaneous Melanoma: A Review|access-date=2025-12-18}}</ref>｜類型：Review｜一句導讀：黑色素瘤 95% 為皮膚型；全球年約 30 萬新案，早期手術、進展期免疫/標靶重點整理。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/article-abstract/2838001|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Recurrent Clostridioides difficile Infections<ref>{{cite web|title=Recurrent Clostridioides difficile Infections|url=https://chatgpt.com/share/Recurrent%20Clostridioides%20difficile%20Infections|publisher=Recurrent Clostridioides difficile Infections|access-date=2025-12-18}}</ref>｜類型：JAMA Insights｜一句導讀：復發 CDI 的診斷、治療與再發預防流程化整理，臨床可直接套用。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> === 全部條目導讀（依輸入出現順序） === ==== This Week in JAMA ==== * Audio Highlights: November 21, 2025<ref>{{cite web|title=Audio Highlights: November 21, 2025|url=https://chatgpt.com/share/Audio%20Highlights:%20November%2021,%202025|publisher=Audio Highlights: November 21, 2025|access-date=2025-12-18}}</ref> 中文標題：音訊精華（2025/11/21） 類型：Audio（This Week in JAMA） 導讀：用短音訊快速掃描本期重點（含肺癌篩檢、周邊神經病變回顧、砷暴露與死亡等），適合作為「先聽再挑文」的入口。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/article-abstract/2842099|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== Original Investigation ==== * An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial<ref>{{cite web|title=An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial|url=https://chatgpt.com/share/An%20AI-Powered%20Lifestyle%20Intervention%20vs%20Human%20Coaching%20in%20the%20Diabetes%20Prevention%20Program:%20A%20Randomized%20Clinical%20Trial|publisher=An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial|access-date=2025-12-18}}</ref> 中文標題：糖尿病預防計畫：AI 生活型態介入 vs 人類教練的隨機試驗 類型：Original study（RCT；AI in Medicine） 導讀：RCT（n=724，前期糖尿病）：AI vs 人類教練。12 月複合達標 42.4% vs 41.4%，差 1.0%（95%CI −6.1～8.1）達非劣；活動量未非劣。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/fullarticle/2840703|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score<ref>{{cite web|title=Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score|url=https://chatgpt.com/share/Development%20and%20Validation%20of%20the%20Sequential%20Organ%20Failure%20Assessment%20(SOFA|publisher=Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score|access-date=2025-12-18}}</ref>-2%20Score) 中文標題：SOFA-2 器官衰竭評分的開發與驗證 類型：Original study（預後/風險評分開發與驗證；Caring for the Critically Ill Patient） 導讀：330 萬成人 ICU 聯邦分析建模驗證；SOFA-2（0–24，納用藥/器官支持）院內死亡 AUROC 0.79 優於 SOFA 0.77，利於重症分層更新；GI/免疫未納入。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/fullarticle/2840822|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Arsenic Exposure Reduction and Chronic Disease Mortality<ref>{{cite web|title=Arsenic Exposure Reduction and Chronic Disease Mortality|url=https://chatgpt.com/share/Arsenic%20Exposure%20Reduction%20and%20Chronic%20Disease%20Mortality|publisher=Arsenic Exposure Reduction and Chronic Disease Mortality|access-date=2025-12-18}}</ref> 中文標題：砷暴露下降與慢性病死亡率 類型：Original study（前瞻性隊列；環境健康） 導讀：前瞻隊列（10,977 人）追蹤至 2022：尿砷每 IQR↓197 μg/g，慢性病死亡 aHR 0.78；高→低於中位數 aHR 0.46，支持砷緩解與死亡下降相關。 PubMed<ref>{{cite web|title=PubMed|url=https://pubmed.ncbi.nlm.nih.gov/41247717/|publisher=pubmed.ncbi.nlm.nih.gov|access-date=2025-12-18}}</ref> ==== Research Letter ==== * Tracking County-Level Measles Cases in the US<ref>{{cite web|title=Tracking County-Level Measles Cases in the US|url=https://chatgpt.com/share/Tracking%20County-Level%20Measles%20Cases%20in%20the%20US|publisher=Tracking County-Level Measles Cases in the US|access-date=2025-12-18}}</ref> 中文標題：美國郡級麻疹病例追蹤平台 類型：Research Letter（病例序列/監測資料） 導讀：介紹可追蹤美國「郡級」麻疹病例的公共資料平台與更新方式，對公衛監測、疫情溝通與資源配置有直接用途。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/fullarticle/2839096|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Emergency Medicaid Spending for Undocumented Immigrants in the US<ref>{{cite web|title=Emergency Medicaid Spending for Undocumented Immigrants in the US|url=https://chatgpt.com/share/Emergency%20Medicaid%20Spending%20for%20Undocumented%20Immigrants%20in%20the%20US|publisher=Emergency Medicaid Spending for Undocumented Immigrants in the US|access-date=2025-12-18}}</ref> 中文標題：美國無證移民的 Emergency Medicaid 支出概況 類型：Research Letter（橫斷面/行政資料分析） 導讀：19 州 Medicaid claims 分析：Emergency Medicaid 佔總支出 2%（0.8%–4.1%），且 85% 支出用於美國出生/合法居留者；可校正政策討論的基線認知。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== Viewpoint ==== * Advisory Committee on Immunization Practices Standards for Assessing Evidence<ref>{{cite web|title=Advisory Committee on Immunization Practices Standards for Assessing Evidence|url=https://chatgpt.com/share/Advisory%20Committee%20on%20Immunization%20Practices%20Standards%20for%20Assessing%20Evidence|publisher=Advisory Committee on Immunization Practices Standards for Assessing Evidence|access-date=2025-12-18}}</ref> 中文標題：ACIP 評估疫苗證據的標準 類型：Viewpoint 導讀：聚焦 ACIP 如何（以及應如何）評讀與分級證據，幫助臨床/公衛讀者理解建議形成、透明度與不確定性溝通的關鍵。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * State Mifepristone Regulation Following GenBioPro v Raynes<ref>{{cite web|title=State Mifepristone Regulation Following GenBioPro v Raynes|url=https://chatgpt.com/share/State%20Mifepristone%20Regulation%20Following%20GenBioPro%20v%20Raynes|publisher=State Mifepristone Regulation Following GenBioPro v Raynes|access-date=2025-12-18}}</ref> 中文標題：GenBioPro v Raynes 後州層級米非司酮管制的變化 類型：Viewpoint（Women's Health；政策/法規） 導讀：梳理判決後各州對 mifepristone 的管制差異與趨勢，適合關注生殖健康服務可近性、醫療機構合規與臨床流程者。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Evolving Hospital-at-Home to Meet the Needs of Children<ref>{{cite web|title=Evolving Hospital-at-Home to Meet the Needs of Children|url=https://chatgpt.com/share/Evolving%20Hospital-at-Home%20to%20Meet%20the%20Needs%20of%20Children|publisher=Evolving Hospital-at-Home to Meet the Needs of Children|access-date=2025-12-18}}</ref> 中文標題：兒科 Hospital-at-Home 的模式演進 類型：Viewpoint（醫療交付模式） 導讀：討論兒科居家住院如何從成人模式調整（安全、照護負擔、支付與公平），可作為建置/擴張兒科 HaH 專案的框架文章。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * The Make America Healthy Again Strategy Report<ref>{{cite web|title=The Make America Healthy Again Strategy Report|url=https://chatgpt.com/share/The%20Make%20America%20Healthy%20Again%20Strategy%20Report|publisher=The Make America Healthy Again Strategy Report|access-date=2025-12-18}}</ref> 中文標題：「Make America Healthy Again」策略報告的公共衛生觀點 類型：Viewpoint（健康政策） 導讀：從公共衛生與政策角度討論該策略報告的重點與可能影響，適合關注健康政策、風險溝通與健康不平等議題的讀者。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== A Piece of My Mind ==== * The Last Night<ref>{{cite web|title=The Last Night|url=https://chatgpt.com/share/The%20Last%20Night|publisher=The Last Night|access-date=2025-12-18}}</ref> 中文標題：最後一夜（醫療人文敘事） 類型：A Piece of My Mind（敘事散文） 導讀：以臨床照護情境書寫「最後一夜」的情感與專業界線；若想從人文視角補足純研究文章讀感，這篇值得快讀。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== Editorial ==== * Artificial Intelligence and Diabetes Prevention<ref>{{cite web|title=Artificial Intelligence and Diabetes Prevention|url=https://chatgpt.com/share/Artificial%20Intelligence%20and%20Diabetes%20Prevention|publisher=Artificial Intelligence and Diabetes Prevention|access-date=2025-12-18}}</ref> 中文標題：AI 與糖尿病預防：社論解讀 類型：Editorial（AI in Medicine） 導讀：搭配 AI vs 人類教練 DPP 試驗閱讀，社論聚焦 AI 介入的可近性、品質控管與監測重點，幫助判斷是否適合大規模部署。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * A Revision to Organ Failure Assessment in Critically Ill Patients<ref>{{cite web|title=A Revision to Organ Failure Assessment in Critically Ill Patients|url=https://chatgpt.com/share/A%20Revision%20to%20Organ%20Failure%20Assessment%20in%20Critically%20Ill%20Patients|publisher=A Revision to Organ Failure Assessment in Critically Ill Patients|access-date=2025-12-18}}</ref> 中文標題：重症器官衰竭評估的修訂：社論 類型：Editorial（重症照護） 導讀：解讀 SOFA-2 的核心改動與臨床意涵（納入治療/器官支持、預測力提升），並提醒使用情境與未涵蓋器官系統等限制。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== Review ==== * Cutaneous Melanoma: A Review<ref>{{cite web|title=Cutaneous Melanoma: A Review|url=https://chatgpt.com/share/Cutaneous%20Melanoma:%20A%20Review|publisher=Cutaneous Melanoma: A Review|access-date=2025-12-18}}</ref> 中文標題：皮膚黑色素瘤：回顧 類型：Review（皮膚科/腫瘤；可做測驗） 導讀：皮膚型占約 95%；全球每年約 30 萬新案、9.6 萬死。早期以手術切除為主，進展期以免疫檢查點抑制與標靶治療；強調早期辨識與多專科照護。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/article-abstract/2838001|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== JAMA Guide to Statistics and Methods ==== * Pattern-Mixture Models for Missing Data<ref>{{cite web|title=Pattern-Mixture Models for Missing Data|url=https://chatgpt.com/share/Pattern-Mixture%20Models%20for%20Missing%20Data|publisher=Pattern-Mixture Models for Missing Data|access-date=2025-12-18}}</ref> 中文標題：缺失資料的 Pattern-Mixture Models 類型：Methods/Statistics（JAMA Guide to Statistics and Methods） 導讀：當缺失資料可能非隨機（MNAR）時，pattern-mixture models 以「缺失模式」分層建模並做敏感度分析，用來檢驗主要結論對缺失假設的穩健性。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/article-abstract/2840739|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== JAMA Insights ==== * Recurrent Clostridioides difficile Infections<ref>{{cite web|title=Recurrent Clostridioides difficile Infections|url=https://chatgpt.com/share/Recurrent%20Clostridioides%20difficile%20Infections|publisher=Recurrent Clostridioides difficile Infections|access-date=2025-12-18}}</ref> 中文標題：反覆性困難梭狀桿菌感染 類型：JAMA Insights（臨床要點） 導讀：以臨床實作角度整理復發 CDI 的診斷、治療選項與再發預防重點；若你在住院場景常遇到 CDI，這篇適合當作流程化複習。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== Editor's Note ==== * AI in the Lab—Will It Really Change Drug Discovery?<ref>{{cite web|title=AI in the Lab—Will It Really Change Drug Discovery?|url=https://chatgpt.com/share/AI%20in%20the%20Lab%E2%80%94Will%20It%20Really%20Change%20Drug%20Discovery|publisher=AI in the Lab—Will It Really Change Drug Discovery?|access-date=2025-12-18}}</ref> 中文標題：實驗室中的 AI：真的會改變藥物發現嗎？ 類型：Editor's Note 導讀：從研究與產業視角檢視 AI 藥物發現的可行環節與瓶頸（仍需實驗驗證/外部驗證），適合想「校準期待值」的讀者短讀。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * “How Strangely Sweet”: Laryngitis and the Quiet Quirkiness of Senryu<ref>{{cite web|title=“How Strangely Sweet”: Laryngitis and the Quiet Quirkiness of Senryu|url=https://chatgpt.com/share/%E2%80%9CHow%20Strangely%20Sweet%E2%80%9D:%20Laryngitis%20and%20the%20Quiet%20Quirkiness%20of%20Senryu|publisher=“How Strangely Sweet”: Laryngitis and the Quiet Quirkiness of Senryu|access-date=2025-12-18}}</ref> 中文標題：《多麼奇異的甜美》：喉炎與 Senryu 的靜默怪奇 類型：Editor's Note（醫療人文） 導讀：以喉炎經驗為引，連結 senryu（短詩）與醫學觀察；屬人文短文，適合放鬆閱讀、換換腦袋。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== Medical News ==== * New Insights on Circadian Health and Cardiometabolic Disease—Light, Sleep, Food, Exercise, and More<ref>{{cite web|title=New Insights on Circadian Health and Cardiometabolic Disease—Light, Sleep, Food, Exercise, and More|url=https://chatgpt.com/share/New%20Insights%20on%20Circadian%20Health%20and%20Cardiometabolic%20Disease%E2%80%94Light,%20Sleep,%20Food,%20Exercise,%20and%20More|publisher=New Insights on Circadian Health and Cardiometabolic Disease—Light, Sleep, Food, Exercise, and More|access-date=2025-12-18}}</ref> 中文標題：生理時鐘與心代謝健康：光、睡眠、飲食與運動的新洞見 類型：Medical News 導讀：報導 AHA 科學聲明：把「時間安排」納入處方（光照、睡眠、進食、運動的節律），作為心代謝風險管理的可操作介入方向。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Gluten Sensitivity Is Common Around the World—Explanations Are Emerging<ref>{{cite web|title=Gluten Sensitivity Is Common Around the World—Explanations Are Emerging|url=https://chatgpt.com/share/Gluten%20Sensitivity%20Is%20Common%20Around%20the%20World%E2%80%94Explanations%20Are%20Emerging|publisher=Gluten Sensitivity Is Common Around the World—Explanations Are Emerging|access-date=2025-12-18}}</ref> 中文標題：全球麩質敏感常見，機轉逐漸明朗 類型：Medical News（Quick Uptakes） 導讀：整理全球非乳糜瀉麩質敏感的盛行與特徵，並討論可能機轉；對消化科/家醫處理「疑似麩質不耐」諮詢有參考價值。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== Medical News in Brief ==== * 2024-2025 COVID-19 Vaccines Protected Against JN.1 Subvariants<ref>{{cite web|title=2024-2025 COVID-19 Vaccines Protected Against JN.1 Subvariants|url=https://chatgpt.com/share/2024-2025%20COVID-19%20Vaccines%20Protected%20Against%20JN.1%20Subvariants|publisher=2024-2025 COVID-19 Vaccines Protected Against JN.1 Subvariants|access-date=2025-12-18}}</ref> 中文標題：2024–2025 COVID-19 疫苗對 JN.1 亞變異株仍具保護 類型：Medical News in Brief 導讀：簡訊整理新一季疫苗對 JN.1 亞變異株的保護訊息，可作為臨床門診與公衛溝通更新的快速素材。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * FDA Approves Nonhormonal Treatment for Menopausal Hot Flashes<ref>{{cite web|title=FDA Approves Nonhormonal Treatment for Menopausal Hot Flashes|url=https://chatgpt.com/share/FDA%20Approves%20Nonhormonal%20Treatment%20for%20Menopausal%20Hot%20Flashes|publisher=FDA Approves Nonhormonal Treatment for Menopausal Hot Flashes|access-date=2025-12-18}}</ref> 中文標題：FDA 核准新的非荷爾蒙停經熱潮紅治療 類型：Medical News in Brief 導讀：更新停經熱潮紅的非荷爾蒙治療選項，對不適合或不願使用荷爾蒙療法的族群，臨床可用來做選項式衛教。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * [Meta-Analysis: Viral Infections May Raise Cardiovascular Risks](Meta-Analysis: Viral Infections May Raise Cardiovascular Risks) 中文標題：荟萃分析：病毒感染後心血管風險可能上升 類型：Medical News in Brief 導讀：以綜合證據角度提醒病毒感染後可能伴隨心血管風險上升，適合用來提醒高風險病人追蹤與二級預防思維。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Bacterial Vaginosis Treatment Should Involve All Partners, ACOG Says<ref>{{cite web|title=Bacterial Vaginosis Treatment Should Involve All Partners, ACOG Says|url=https://chatgpt.com/share/Bacterial%20Vaginosis%20Treatment%20Should%20Involve%20All%20Partners,%20ACOG%20Says|publisher=Bacterial Vaginosis Treatment Should Involve All Partners, ACOG Says|access-date=2025-12-18}}</ref> 中文標題：ACOG：細菌性陰道炎治療應納入所有伴侶 類型：Medical News in Brief 導讀：反映對再感染控制的新立場（治療對象擴及所有伴侶）；臨床端可先讀這則簡訊，再回頭查實務指引細節。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Updated Flu, RSV Vaccination Recommendations for Immunocompromised People<ref>{{cite web|title=Updated Flu, RSV Vaccination Recommendations for Immunocompromised People|url=https://chatgpt.com/share/Updated%20Flu,%20RSV%20Vaccination%20Recommendations%20for%20Immunocompromised%20People|publisher=Updated Flu, RSV Vaccination Recommendations for Immunocompromised People|access-date=2025-12-18}}</ref> 中文標題：免疫功能低下者流感與 RSV 疫苗建議更新 類型：Medical News in Brief 導讀：快速更新免疫功能低下者的流感/RSV 接種建議，對門診接種排程、衛教與風險溝通有直接應用價值。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * [AAP: Leucovorin Not Recommended for Autism](AAP: Leucovorin Not Recommended for Autism) 中文標題：AAP：不建議以 Leucovorin 治療自閉症 類型：Medical News in Brief 導讀：提供門診面對補充/替代療法詢問時的依據與溝通起點；若常遇到家長提及 leucovorin，可先讀此則抓重點。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== Poetry and Medicine ==== * Hush<ref>{{cite web|title=Hush|url=https://chatgpt.com/share/Hush|publisher=chatgpt.com|access-date=2025-12-18}}</ref> 中文標題：《安靜》 類型：Poetry and Medicine 導讀：本期詩作短讀，適合在密集研究文章之間換個節奏。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== JAMA Revisited ==== * Sunshine and Health<ref>{{cite web|title=Sunshine and Health|url=https://chatgpt.com/share/Sunshine%20and%20Health|publisher=Sunshine and Health|access-date=2025-12-18}}</ref> 中文標題：日照與健康（JAMA Revisited） 類型：JAMA Revisited（歷史回顧） 導讀：重讀歷史內容，回顧「日照與健康」的早期醫學論述；適合教學、人文或醫史興趣讀者。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== JAMA Patient Page ==== * Early-Onset Gastrointestinal Cancer<ref>{{cite web|title=Early-Onset Gastrointestinal Cancer|url=https://chatgpt.com/share/Early-Onset%20Gastrointestinal%20Cancer|publisher=Early-Onset Gastrointestinal Cancer|access-date=2025-12-18}}</ref> 中文標題：早發性腸胃道癌症（病人衛教頁） 類型：JAMA Patient Page（Patient Info） 導讀：以病人友善語言整理風險因子、警訊症狀與可能檢查/治療，適合門診衛教、共享決策或做成衛教單張。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== Audio ==== * Lung Cancer Screening Benefits, Peripheral Neuropathy Review, Arsenic Exposure and Mortality, and more<ref>{{cite web|title=Lung Cancer Screening Benefits, Peripheral Neuropathy Review, Arsenic Exposure and Mortality, and more|url=https://chatgpt.com/share/Lung%20Cancer%20Screening%20Benefits,%20Peripheral%20Neuropathy%20Review,%20Arsenic%20Exposure%20and%20Mortality,%20and%20more|publisher=Lung Cancer Screening Benefits, Peripheral Neuropathy Review, Arsenic Exposure and Mortality, and more|access-date=2025-12-18}}</ref> 中文標題：本期音訊總覽：肺癌篩檢、周邊神經病變回顧、砷暴露與死亡等 類型：Audio 導讀：一集把多篇內容串成「可吸收的主線」，適合通勤快聽抓大方向，再回頭挑想深入的研究/評論文章。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/article-abstract/2842099|publisher=JAMA Network|access-date=2025-12-18}}</ref> * The Sequential Organ Failure Assessment (SOFA)-2 Score<ref>{{cite web|title=The Sequential Organ Failure Assessment (SOFA)-2 Score|url=https://chatgpt.com/share/The%20Sequential%20Organ%20Failure%20Assessment%20(SOFA|publisher=The Sequential Organ Failure Assessment (SOFA)-2 Score|access-date=2025-12-18}}</ref>-2%20Score) 中文標題：SOFA-2 評分：Podcast 導讀 類型：Audio（Podcast） 導讀：聚焦 SOFA-2 的新增構面與臨床使用情境，對 ICU 團隊評估是否導入新評分、如何解讀分數變化很有幫助。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/learning/audio-player/19013724|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Diagnosis and Management of Cutaneous Melanoma<ref>{{cite web|title=Diagnosis and Management of Cutaneous Melanoma|url=https://chatgpt.com/share/Diagnosis%20and%20Management%20of%20Cutaneous%20Melanoma|publisher=Diagnosis and Management of Cutaneous Melanoma|access-date=2025-12-18}}</ref> 中文標題：皮膚黑色素瘤的診斷與治療：Podcast 導讀 類型：Audio（Podcast） 導讀：用臨床觀點帶讀黑色素瘤從辨識、診斷到治療路徑，適合皮膚科/腫瘤科/家醫作為快速複習。 edhub.ama-assn.org<ref>{{cite web|title=edhub.ama-assn.org|url=https://edhub.ama-assn.org/jn-learning/audio-player/18997466|publisher=edhub.ama-assn.org|access-date=2025-12-18}}</ref> * AI for Drug Discovery<ref>{{cite web|title=AI for Drug Discovery|url=https://chatgpt.com/share/AI%20for%20Drug%20Discovery|publisher=AI for Drug Discovery|access-date=2025-12-18}}</ref> 中文標題：AI 用於藥物發現：Podcast 導讀 類型：Audio（Podcast） 導讀：從 drug discovery 流程切入，討論 AI 可用場景與限制；若你關注轉譯研究或新藥研發，這集可快速對齊語境。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/learning/audio-player/19015752|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== Comment & Response ==== * Telehealth and Online Cognitive Behavioral Therapy–Based Treatments for High-Impact Chronic Pain<ref>{{cite web|title=Telehealth and Online Cognitive Behavioral Therapy–Based Treatments for High-Impact Chronic Pain|url=https://chatgpt.com/share/Telehealth%20and%20Online%20Cognitive%20Behavioral%20Therapy%E2%80%93Based%20Treatments%20for%20High-Impact%20Chronic%20Pain|publisher=Telehealth and Online Cognitive Behavioral Therapy–Based Treatments for High-Impact Chronic Pain|access-date=2025-12-18}}</ref> 中文標題：遠距/線上 CBT 慢性疼痛治療研究的讀者來函（之一） 類型：Comment & Response 導讀：就「遠距與線上 CBT 治療高衝擊慢性疼痛」研究提出解讀/方法學意見；若你讀過原研究，這封來函可快速看到爭點。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Telehealth and Online Cognitive Behavioral Therapy–Based Treatments for High-Impact Chronic Pain<ref>{{cite web|title=Telehealth and Online Cognitive Behavioral Therapy–Based Treatments for High-Impact Chronic Pain|url=https://chatgpt.com/share/Telehealth%20and%20Online%20Cognitive%20Behavioral%20Therapy%E2%80%93Based%20Treatments%20for%20High-Impact%20Chronic%20Pain|publisher=Telehealth and Online Cognitive Behavioral Therapy–Based Treatments for High-Impact Chronic Pain|access-date=2025-12-18}}</ref> 中文標題：遠距/線上 CBT 慢性疼痛治療研究的讀者來函（之二） 類型：Comment & Response 導讀：另一組作者針對同一主題提出補充觀點；適合想掌握不同讀者如何詮釋同一試驗結果的人快速掃讀。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Telehealth and Online Cognitive Behavioral Therapy–Based Treatments for High-Impact Chronic Pain—Reply<ref>{{cite web|title=Telehealth and Online Cognitive Behavioral Therapy–Based Treatments for High-Impact Chronic Pain—Reply|url=https://chatgpt.com/share/Telehealth%20and%20Online%20Cognitive%20Behavioral%20Therapy%E2%80%93Based%20Treatments%20for%20High-Impact%20Chronic%20Pain%E2%80%94Reply|publisher=Telehealth and Online Cognitive Behavioral Therapy–Based Treatments for High-Impact Chronic Pain—Reply|access-date=2025-12-18}}</ref> 中文標題：作者回覆：遠距/線上 CBT 慢性疼痛治療研究 類型：Comment & Response（Reply） 導讀：原作者回覆並澄清研究設計與結果詮釋，提供「如何讀懂這篇研究」的關鍵線索；建議與來函對照閱讀。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Review on Uveitis<ref>{{cite web|title=Review on Uveitis|url=https://chatgpt.com/share/Review%20on%20Uveitis|publisher=Review on Uveitis|access-date=2025-12-18}}</ref> 中文標題：葡萄膜炎回顧文的讀者來函 類型：Comment & Response 導讀：針對 uveitis 回顧文章提出補充/質疑與臨床提醒；若你在眼科或內科常遇到 uveitis，這類來函可抓到爭議點。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Review on Uveitis—Reply<ref>{{cite web|title=Review on Uveitis—Reply|url=https://chatgpt.com/share/Review%20on%20Uveitis%E2%80%94Reply|publisher=Review on Uveitis—Reply|access-date=2025-12-18}}</ref> 中文標題：作者回覆：葡萄膜炎回顧文 類型：Comment & Response（Reply） 導讀：作者回覆並補充其建議的理由與證據來源；適合在讀者來函後，用來釐清回顧文的臨床立場。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Lower Urinary Tract Symptoms in Males<ref>{{cite web|title=Lower Urinary Tract Symptoms in Males|url=https://chatgpt.com/share/Lower%20Urinary%20Tract%20Symptoms%20in%20Males|publisher=Lower Urinary Tract Symptoms in Males|access-date=2025-12-18}}</ref> 中文標題：男性下泌尿道症狀（LUTS）議題讀者來函（之一） 類型：Comment & Response 導讀：針對男性 LUTS 的評估/治療觀點提出來函意見；可用來快速掃描臨床共識與分歧，之後再回讀原文更有效率。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Lower Urinary Tract Symptoms in Males<ref>{{cite web|title=Lower Urinary Tract Symptoms in Males|url=https://chatgpt.com/share/Lower%20Urinary%20Tract%20Symptoms%20in%20Males|publisher=Lower Urinary Tract Symptoms in Males|access-date=2025-12-18}}</ref> 中文標題：男性下泌尿道症狀（LUTS）議題讀者來函（之二） 類型：Comment & Response 導讀：另一封針對 LUTS 的補充/不同角度來函；若你在泌尿科/家醫門診常處理 LUTS，建議與其他來函並讀抓重點。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Lower Urinary Tract Symptoms in Males<ref>{{cite web|title=Lower Urinary Tract Symptoms in Males|url=https://chatgpt.com/share/Lower%20Urinary%20Tract%20Symptoms%20in%20Males|publisher=Lower Urinary Tract Symptoms in Males|access-date=2025-12-18}}</ref> 中文標題：男性下泌尿道症狀（LUTS）議題讀者來函（之三） 類型：Comment & Response 導讀：第三封針對 LUTS 的來函意見，提供不同作者的臨床詮釋；適合用來補齊指引解讀與實務落地的盲點。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> * Lower Urinary Tract Symptoms in Males—Reply<ref>{{cite web|title=Lower Urinary Tract Symptoms in Males—Reply|url=https://chatgpt.com/share/Lower%20Urinary%20Tract%20Symptoms%20in%20Males%E2%80%94Reply|publisher=Lower Urinary Tract Symptoms in Males—Reply|access-date=2025-12-18}}</ref> 中文標題：作者回覆：男性 LUTS 議題 類型：Comment & Response（Reply） 導讀：作者整合多封來函的焦點並回覆，適合用來釐清 LUTS 評估與治療路徑的核心邏輯；建議作為總結段閱讀。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> ==== JAMA Masthead ==== * JAMA<ref>{{cite web|title=JAMA|url=https://chatgpt.com/share/JAMA|publisher=chatgpt.com|access-date=2025-12-18}}</ref> 中文標題：JAMA 編輯與委員名錄（Masthead） 類型：JAMA Masthead 導讀：列出期刊編輯、編委與工作人員名錄；臨床讀者可略過，但投稿、引用或查詢期刊運作資訊時很實用。 JAMA Network<ref>{{cite web|title=JAMA Network|url=https://jamanetwork.com/journals/jama/issue/334/23|publisher=JAMA Network|access-date=2025-12-18}}</ref> == References == <references /> [[Category:ChatGPT Shares]] [[Category:openai]]
Summary:
Please note that all contributions to freem are considered to be released under the Creative Commons Attribution-ShareAlike 4.0 (see
Freem:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Cite web
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:Citation/CS1/styles.css
(
edit
)
